Allogene Therapeutics Reports First Quarter 2025 Financial Results and Business Update

Go back to Allogene Therapeutics Reports First Quarter 2025 Financial Results and Business Update
(NASDAQ: ALLO) Delayed: 1.99 --0 (-0%)
Previous Close $1.99    52 Week High
Open $1.99    52 Week Low
Day High $1.99    P/E N/A 
Day Low $1.99    EPS
Volume 6,890